Spots Global Cancer Trial Database for Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .
Official Title: A Prospective, Single-arm, Multicenter, Non-interventional Real-world Study of Toripalimab Injection in the Treatment of Malignant Tumors in Chinese Population.
Study ID: NCT04234620
Interventions
Study Description
Brief Summary: This study was a prospective, single-arm, multi-channel, multicenter, non-interventional real-world study to evaluate the safety and efficacy of Toripalimab injection in the treatment of unresectable or metastatic melanoma with previously systemic failure . The study population currently included only in the melanoma cohort-unresectable or metastatic melanoma patients who had previously failed systemic therapy. If new indications are approved during the implementation of the project, patients with new indications using Toripalimab injection will also be included in this study as a new cohort.This study uses offline (physical hospital) and online (DTP pharmacy and Lingke (Yinchuan) Internet hospital) to collect data and information, relying on Lingke technology (Beijing) Co., Ltd. EDC (Medical Research Cloud) database for data collection and processing. The classification of adverse events was based on the general toxicity evaluation standard NCI CTCAE 5.0 of the National Institute of Oncology (Chinese version).
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Beijing Cancer Hospital, Beijing, Beijing, China
Cancer Hospital Chinese Academy of Medical Science, Beijing, , China
The first affiliated Hospital of Jinlin Universtiy, Changchun, , China
Hunan cancer hospital, Changsha, , China
Xiangya Hospital Central South University, Changsha, , China
Chongqing Haijiya Cancer Hospital, Chongqing, , China
Fujian province cancer hospital, Fuzhou, , China
Zhejiang cancer hospital, Hangzhou, , China
Harbin Medical University Cancer Hospital, Harbin, , China
Qilu Hospital of Shandong university, Jinan, , China
Shandong province cancer hospital, Jinan, , China
Affiliated Cancer Hospital of Guangxi Medical university, Nanjing, , China
Najing Drum Tower Hospital, Nanjing, , China
Fudan University Shanghai Cancer Center, Shanghai, , China
Shanxi Bethune Hopital, Shanxi, , China
The fouth Hospital of Hebei Medical University, Shijiazhuang, , China
The Second affiliated Hospital of Suzhou Universtiy, Suzhou, , China
Tianjin Medical University cancer institute & Hospital, Tianjin, , China
Hubei cancer hospital, Wuhan, , China
Tongji Medical College of Huazhong University of Science & Technology, Wuhan, , China
Wuhan Union Hospital, Wuhan, , China
The first affiliated Hospital of Xiamen Universtiy, Xiamen, , China
Yinchuan Lingke Internet Hosipital, Yinchuan, , China
Affiliated Hopital of Guangdong Medical University, Zhanjiang, , China
Henan cancer hospital, Zhengzhou, , China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
